American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6399)
  2. Solid Tumor Oncology Division (5537)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1379)
  9. Gastrointestinal Oncology Service (1353)
  10. Hematologic Malignancies, Division of (1281)
Search Within
Formats
  1. Meeting Abstract (6334)
  2. Journal Article (2579)
  3. Editorial (76)
  4. Review (68)
  5. Guidelines (54)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6399)
  2. Solid Tumor Oncology Division (5537)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (275)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8694)
  2. JCO Precision Oncology (171)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (7)

More Publications

Results (9167)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 results of the WEE1 inhibitor, azenosertib, in combination with gemcitabine (gem) in adult and pediatric patients (pts) with relapsed or refractory (R/R) osteosarcoma
    Meeting Abstract

    Avutu, V.; Livingston, J. A.; Federman, N.; Cranmer, L. D.; Gaspar, N.; Toulmonde, M.; Pressey, J. G.; Brahmi, M.; Poklepovic, A. S.; Shi, Q.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Shareable artificial intelligence to extract cancer outcomes from electronic health records
    Meeting Abstract

    Kehl, K. L.; Jee, J.; Pichotta, K.; Trukhanov, P.; Fong, C.; Waters, M.; Nichols, C.; Cerami, E.; Schrag, D.; Schultz, N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The influence of access to care on radiation therapy utilization among older women with breast cancer
    Meeting Abstract

    MeLampy, J.; Chen, M. H.; Mazumdar, M.; Klein, P.; Marcadis, A.; Marti, J. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1, in solid tumors, as monotherapy or in combination with pembrolizumab
    Meeting Abstract

    Kyi, C.; Van Dongen, M.; Rottey, S.; Bermejo, I. M.; Mittag, D.; Gouveia, D.; Bol, K.; Yan, C.; Joe, A. K.; Laus, G.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US
    Meeting Abstract

    Razavi, P.; Ahmed, M.; Roush, A.; Parikh, R.; Hitchens, A.; Shen, S.; Safonov, A.; Jhaveri, K. L.; Robson, M. E.; Peacock, N. W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study evaluating the effect of IMNN-001 on second-look laparoscopy (SLL) when administered in combination with bevacizumab (BEV) and neoadjuvant chemotherapy (NACT) in patients newly diagnosed with advanced epithelial ovarian cancer (EOC)
    Meeting Abstract

    Jazaeri, A. A.; Grisham, R. N.; Gaillard, S.; How, J. A.; Hazard, S.; Musso, L.; Kyi, C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • First-line treatment preferences for advanced melanoma among oncologists and patients in the US: A discrete choice experiment
    Meeting Abstract

    Postow, M. A.; Burgos, G.; DeCongelio, M.; Palaia, J.; Ejzykowicz, F.; Patel, D.; Rosenblatt, L.; Modi, K.; Pittman, Z.; Honomichl, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Immune-related adverse event prediction and influential factor identification
    Meeting Abstract

    Zhang, Y.; Lev-Ari, S.; Shah, N. J.; Gupta, S.; Zaemes, J. P.; Alaoui, A.; McGarvey, P.; Atkins, M. B.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Whole exome correlates in metastatic hormone sensitive prostate cancer (mHSPC): Results from E3805 CHAARTED
    Meeting Abstract

    Hamid, A.; Vergara, M.; Park, J.; Chinsky, T. M.; Aldubayan, S.; Grist, E.; Attard, G.; Van Allen, E. M.; Sweeney, C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Resident physicians' knowledge, attitudes, and practices on advance care planning for patients with advanced cancer in a national university hospital in the Philippines
    Meeting Abstract

    Ting, F. I. L.; Estreller, S. S.; Pilapil, J. C. A.; Real, I. O.; Dee, E. C. C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save